Literature DB >> 18342203

Solar ultraviolet B radiation compared with prostate cancer incidence and mortality rates in United States.

Janet L Colli1, William B Grant.   

Abstract

OBJECTIVE: To investigate whether the prostate cancer incidence and mortality rates in the United States correlate inversely with solar ultraviolet (UV) B radiation levels computed from a mathematical model using forecasted ozone levels, cloud levels, and elevation. Another objective was to explore whether the annual prostate cancer rates correlated more strongly with the cumulative UVB exposure for the year or for exposure during certain seasons.
METHODS: The age-adjusted incidence and mortality cancer rates for black and white men in the continental United States were correlated with the mean UV index values averaged for the year and for each season.
RESULTS: We found an inverse correlation between the UVB levels and prostate cancer incidence (R = -0.42, P <0.01) and mortality rates (R = -0.53, P <0.001) for white men and for incidence (R = -0.40, P <0.05) for black men, but the strength of the correlation depended on the season of UVB irradiance. No statistically significant results for black male mortality were found. The annual prostate cancer incidence and mortality rates for white men correlated most strongly with UVB exposure levels in the fall and winter, and incidence rates for black men correlated with UVB exposure levels in the summer.
CONCLUSIONS: Increased solar UVB radiation might reduce the risk of prostate cancer, but the efficacy depends on the season of UVB irradiance.

Entities:  

Mesh:

Year:  2008        PMID: 18342203     DOI: 10.1016/j.urology.2007.10.050

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  9 in total

1.  Pesticide exposure and inherited variants in vitamin d pathway genes in relation to prostate cancer.

Authors:  Sara Karami; Gabriella Andreotti; Stella Koutros; Kathryn Hughes Barry; Lee E Moore; Summer Han; Jane A Hoppin; Dale P Sandler; Jay H Lubin; Laurie A Burdette; Jeffrey Yuenger; Meredith Yeager; Laura E Beane Freeman; Aaron Blair; Michael C R Alavanja
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-07-05       Impact factor: 4.254

2.  Critique of the U-shaped serum 25-hydroxyvitamin D level-disease response relation.

Authors:  William B Grant
Journal:  Dermatoendocrinol       Date:  2009-11

3.  The relationship between ultraviolet light exposure and mortality in dialysis patients.

Authors:  Bryan B Shapiro; Elani Streja; Joline L T Chen; Csaba P Kovesdy; Kamyar Kalantar-Zadeh; Connie M Rhee
Journal:  Am J Nephrol       Date:  2014-10-11       Impact factor: 3.754

Review 4.  Chemoprevention of prostate cancer: what can be recommended to patients?

Authors:  Janet L Colli; Christopher L Amling
Journal:  Curr Urol Rep       Date:  2009-05       Impact factor: 3.092

5.  How strong is the evidence that solar ultraviolet B and vitamin D reduce the risk of cancer?: An examination using Hill's criteria for causality.

Authors:  William B Grant
Journal:  Dermatoendocrinol       Date:  2009-01

6.  Circulating levels of 25-hydroxyvitamin D and prostate cancer prognosis.

Authors:  Sarah K Holt; Suzanne Kolb; Rong Fu; Ronald Horst; Ziding Feng; Janet L Stanford
Journal:  Cancer Epidemiol       Date:  2013-08-20       Impact factor: 2.984

7.  Vitamin d, sunlight and prostate cancer risk.

Authors:  Krishna Vanaja Donkena; Charles Y F Young
Journal:  Adv Prev Med       Date:  2011-06-08

8.  Sunlight exposure during leisure activities and risk of prostate cancer in Montréal, Canada, 2005-2009.

Authors:  Jennifer Yu; Jérôme Lavoué; Marie-Élise Parent
Journal:  BMC Public Health       Date:  2014-07-28       Impact factor: 3.295

Review 9.  Common variants of the vitamin D binding protein gene and adverse health outcomes.

Authors:  Suneil Malik; Lei Fu; David James Juras; Mohamed Karmali; Betty Y L Wong; Agnes Gozdzik; David E C Cole
Journal:  Crit Rev Clin Lab Sci       Date:  2013-02-22       Impact factor: 6.250

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.